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Background: The association between adiposity in early adulthood and subsequent development of speciﬁc
malignancies is unclear. Further, the potential for mediation by adiposity in middle age has not been well examined. In
a rare study, we investigated the association of body mass index (BMI) in early adulthood with mortality from several
site-speciﬁc cancers.
Design: In the Harvard Alumni Health Study cohort, 19 593males had a physical examination atthe university between
1914 and 1952 (mean age: 18.4 years) and returned a questionnaire in 1962 or 1966 (mean age = 45.1 years). BMI was
computed using weight (kg)/height
2 (m
2) at both time points. Vital status follow up continued for a maximum of 82 years.
Results: Positive early adulthood cancer mortality gradients by BMI were found for all malignancies combined
(adjusted hazard ratio [HR] = 1.11; 95% conﬁdence interval [CI]: 1.05–1.17 for a one standard deviation increase in
early adulthood BMI), and for lung (HR = 1.24; 95% CI = 1.10–1.40) and skin (HR = 1.29; 95% CI = 0.96–1.75)
cancers. There were also apparent associations for cancers of the oesophagus and urogenital sites. Mediation by BMI
in middle age was found to be minimal.
Conclusion: Higher BMI in early adulthood appears to be a direct risk factor for selected malignancies several
decades later.
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introduction
A series of studies have examined the link between adiposity,
measured in middle- and older-aged adults, and subsequent cancer
development [1, 2]. Positive associations between body mass index
(BMI), the most commonly used index of adiposity, and some site-
speciﬁcmalignancies—includingcolon,rectum,kidney,melanoma
and pancreas—have been shown [2]. Physiological mechanisms
including metabolic disturbance have been posited as plausible
explanations for these observed associations [3]. However, despite
thegrowingprevalenceofobesityearlierinlife,thelong-termhealth
consequences of obesity in early adulthood have not been well
exami ned .T hi sisduetoap aucityofcoh or tsofyo ungp erso nswit h
BMImeasurementwhoarethenfollowedforseveraldecadesforthe
occurrence of cancer.
In thefew studies relating body weightduring early adulthood
withfuturecancerrisk,thenumberofeventsislowandstatistical
power is therefore sub-optimal [1, 4–6]. Other methodological
constraints exist. Some studies [1, 5] suffer from an absence of
covariate data to assess the effect of confounding [7], while in
others, the potentially mediating role of adiposity in middle age
has not been explored [8]. This latter issue is particularly
important since overweight young adults tend to remain
overweight into middle age [9], such that the inﬂuence of excess
weightduringearlyadulthoodonfuturecancerriskcouldsimply
be a result of perpetuated middle-aged adiposity.
The Harvard Alumni Health Study is a large prospective
cohort with data collected across the entire adult life course. It
therefore represents a rare opportunity to examine the
associations of BMI during both early and middle adulthood
with the risk of total and site-speciﬁc cancer mortality.
methods
study population
The Harvard Alumni Health Study is an ongoing cohort study of chronic
disease risk factors in male undergraduates at the Harvard University,
Boston, USA who matriculated between 1916 and 1950. A total of 33 415
men took part in a standardised, routine medical examination at 18 years
of age (‘early adulthood’) [10, 11]. Measurements of height and weight were
made and students responded to enquiries regarding smoking habits (never,
past or current) [10, 12]. Details on physical activity (<2, 2 to <5, ‡5 h/week
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during their undergraduate years [11].
Health questionnaires have been mailed to surviving alumni on
a periodic basis since either 1962 or 1966 (hereafter referred to as
1962/1966), when they were aged, on average, 46 years (‘middle age’). These
questionnaires included questions about height and weight; it has been
previously shown that these self-reported data have a high level of
agreement with direct measurement of height and weight [12]. A total of
21 582 men (68% of surviving alumni) responded to the 1962/1966
questionnaire [13].
ascertainment of cancer mortality
We used documentation maintained by the Harvard University Alumni
ofﬁce to periodically identify decedents during follow-up and obtained
copies of ofﬁcial death certiﬁcates from the state health departments
through the end of 1998 to determine cause of death. Records are over 99%
complete for vital status in this cohort [14]. Cancer deaths were coded
according to the Seventh Revision of the International Classiﬁcation of
Disease (ICD 420) [15]. Deaths from any cancer were identiﬁed by ICD-7
codes 140-239. The cancer sites selected were those with at least 50 deaths
for the purposes of model stability. We therefore considered the following
individual cancer sites: trachea, bronchus and lung (ICD-7: 162-163;
referred to as ‘lung cancer’); colon (153); colorectal (153-154); stomach
(151); liver (155-156); pancreas (157); prostate (177); kidney (180); bladder
(181); oesophageal (150); brain (193); skin (190-191); lymphoma
(200-202); multiple myeloma (203) and leukaemia (204). Additionally,
cancers of the kidney, bladder, prostate and testis were considered in
a group (177-181; referred to as ‘urogenital’), as were neoplasms from
lymphatic and haematopoietic tissues (200-205).
statistical analyses
BMI was calculated (weight [kg]/height
2 [m
2]) for early adulthood and
middle age, and we categorised values into quartiles. We also utilised
current World Health Organisation (WHO) classiﬁcations for underweight
(<18.5 kg/m
2), normal weight (18.5 to <25 kg/m
2; referent), overweight
(25 to <30 kg/m
2) and obesity (‡30 kg/m
2)[ 16].
Of the 33 415 men who were medically examined in early adulthood,
2663 (8%) died before 1962 and 10 902 were not traced or did not respond
to the questionnaire mailing. This resulted in a total of 19 850 men who had
both records of a physical examination at college entry and returned
a mailed questionnaire in 1962/1966 (Figure 1). Data on participants were
discarded on the basis of data errors with recorded dates for university
entry and death (n = 29), and missing information on height and weight at
the medical examination (n = 228), leaving 19 593 men in the present study.
In further analyses, we limited the sample to men with complete data on
height and weight from the 1962/1966 questionnaire and potentially
confounding variables (n = 15 781). The subjects excluded from the analysis
had similar distribution of BMI at college entry to the analytical sample
(mean = 21.7 kg/m
2, standard deviation [SD] = 2.6 kg/m
2 and mean = 21.7
kg/m
2,S D= 2.5 kg/m
2, respectively).
Having determined that the proportional hazards assumption had not
been violated, hazard ratios (HRs) and 95% conﬁdence intervals (CIs) were
computed using Cox regression models [17] to summarise the relationship
of BMI in early and middle adulthood with subsequent total and site-
speciﬁc cancer mortality; deaths from any other cause (including alternative
cancers) were censored. In these analyses, we explored the association of
BMI expressed as both a categorical variable and a 1 SD increase in relation
to the site-speciﬁc cancers. In model 1, we adjusted for age only; we then
adjusted for BMI at middle age in model 2, and ﬁnally, in model 3, we also
controlled for cigarette smoking status and physical activity during early
adulthood. We also obtained estimates from joint models to establish the
direct effects of BMI in early adulthood. To guard against the possibility of
middle-age BMI ﬁndings being affected by reverse causality—whereby
potential bias would arise from possible weight loss caused by occult disease
impacting on BMI—we carried out sensitivity analyses excluding 161
deaths occurring within 3 years following questionnaire return [18]. Also,
all analyses were reconducted accounting for parental history of cancer
(present for 308 men). To account for missing data—affecting at least one
variable for 4040 men—survival analyses were also carried out on 21
multiply imputed datasets (corresponding to the percentage with missing
data [19]). This was based on the chained equations procedure [20] and
included all 19 821 men with valid dates and records for physical
examination at university entry and 1962/1966 questionnaire. Finally, we
produced effect estimates based on a subset of men with no missing data on
BMI and potential confounders (n = 15 781).
results
The overall mean BMI increased by 2.7 kg/m
2 from 21.7 kg/m
2
in early adulthood (mean age = 18.4, SD = 1.8) to 24.4 kg/m
2 in
middle adulthood (mean age = 46.1, SD = 9.4), and the two
measures were signiﬁcantly correlated (r = 0.49, P < 0.001). In
Table 1, we show the relationships between early adulthood
BMI and the study members’ characteristics.
The men were followed for cause-speciﬁc mortality for
a mean of 56.5 years from university entry. In total, 2395 men
died of a malignancy of some kind (mortality rate of 217 per
100 000 person years): 469 (42) of the lung, 228 (21) of the
colon, 270 (24) of colorectal, 145 (13) of pancreas, 417 (38) of
prostate, 535 (48) of urogenital, 66 (6) of skin, 82 (7) of
oesophageal, 67 (7) of stomach, 69 (21) of liver, 55 (6)
of kidney, 60 (5) of bladder, 85 (8) of brain, 149 (13) of
lymphoma, 58 (52) of multiple myeloma, 119 (11) of leukaemia
and 328 (30) of lymphatic and haematopoietic tissues. These
results broadly accord with cancer mortality statistics for the
Alive in 1962 
(n=30,752) 
Responded to the 1962/1966 questionnaire
a
(mean age 45.1 years)  
(n=19,850) 
Died prior to 1962 
(n=2,663) 
Not traced or did 
not respond to 
questionnaire
(n=10,902) 
Physical examination at college entry, 1914 to 





Missing BMI data at 
college entry 
 (n=228) 
Correct dates for college entry in 1914 to 
1952 (mean age 18.4 years) and death  
(n=19,821)
Errors with recorded 
dates for college entry 
and death (n=29) 
Figure 1. Participants in the Harvard Alumni study. a indicates 1732 men
of the total 21 582 alumni responding in 1962/1966 were not examined at
college entry. b indicates analytical sample for Model 1 that consisted of
19 593 men; 598 men had missing BMI data in 1962/1966, resulting in n =
18 995 in the analytical sample for Model 2; 3214 men had missing
cigarette smoking status and physical activity in college leaving n = 15 781
in the analytical sample for Model 3.
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with 217 in our cohort), although for some individual sites, e.g.
lung cancer, deaths are fewer due to the relatively low-smoking
prevalence in the cohort [21].
Table 2 gives the relative risk estimates for the associations
between BMI at both early and middle adulthood and mortality
from any malignancy. For BMI at early adulthood, the age-
adjusted BMI at university entry was associated with death from
all malignancies combined, with an 8% (95% CI 4% to 13%)
increased risk for every 1 SD BMI increase. Elevation in risk was
stepwise across quartiles of BMI (Ptrend < 0.001) such that men
in the highest quartile, with a BMI >23 kg/m
2, had a 27%
(13% to 43%) increased risk compared with those with a BMI
<20 kg/m




comparison to early BMI, associations were weaker for middle-
age BMI in relation to any malignancy risk (Table 2).
A 1 SD increase in early adulthood BMI resulted in a 11%
(2%–20%) increased risk of lung cancer mortality (Table 3).
Results for quartiles of early adulthood BMI are shown for all
malignancies in supplemental Table S1 (available at Annals of
Oncology online). Men in the third and fourth quartiles had an
50%elevatedriskoflungcancermortalitycomparedwiththose
in the ﬁrst quartile of BMI (Ptrend = 0.001). HRs strengthened
after adjustment for middle-age BMI, early adulthood smoking
and physical activity. Results for quartiles of middle-age BMI are
Table 1. Characteristics of study participants according to BMI at university entry (N = 19 593)














(N = 19 821)
University entry
Age (years), mean (SD) 18.1 (1.5) 18.2 (1.6) 18.4 (1.8) 18.8 (2.2) 18.4 (1.8)
Physical activity, n (%):
<1 h/week
3.1 (140) 3.0 (142) 3.2 (152) 3.2 (153) 3.1 (587)
Current smoker, n (%):
Yes
33.9 (1337) 34.9 (1462) 34.7 (1481) 34.7 (1491) 34.6 (5771)
Middle age
Age (years), mean (SD) 48.0 (9.4) 47.0 (9.5) 45.6 (9.3) 43.8 (8.9) 46.1 (9.4)
BMI quartile, n (%)
<22.8 kg/m
2 45.9 (2182) 28.7 (1,410) 17.2 (864) 6.5 (321) 24.4 (4777)
22.8 to <24.3 kg/m
2 25.3 (1204) 28.6 (1404) 27.5 (1377) 15.1 (740) 24.1 (4725)
24.3 to <25.8 kg/m
2 16.9 (803) 24.1 (1186) 29.3 (1467) 26.6 (1305) 24.3 (4761)
‡25.8 kg/m
2 8.9 (422) 15.4 (756) 23.3 (1166) 48.6 (2388) 24.2 (4732)
Unknown 3.0 (143) 3.2 (159) 2.7 (137) 3.2 (159) 3.1 (598)
BMI, body mass index; SD, standard deviation.
Table 2. HRs (95% CIs) for mortality from all malignancies in relation to BMI in early adulthood and middle age
BMI range (kg/m
2) Deaths Total Model 1, HR (95% CI) Model 2, HR (95% CI) Model 3, HR (95% CI)
Early adulthood (18.4 years)
Per 1 SD (2.56) increase 2395 19 593 1.08 (1.04–1.13) 1.08 (1.03–1.13) 1.11 (1.05–1.17)
Quartiles <20.0 606 4754 1.00 (ref) 1.00 1.00
20.0 to 21.3 598 4915 1.01 (0.90–1.13) 1.01 (0.90–1.14) 1.03 (0.90–1.17)
21.4 to 23.0 608 5011 1.11 (0.99–1.24) 1.11 (0.99–1.25) 1.10 (0.96–1.26)
>23.0 583 4913 1.27 (1.13–1.43) 1.26 (1.11–1.43) 1.35 (1.17–1.56)
Ptrend
a <0.001 <0.001 <0.001
Middle age (46.1 years)
Per 1 SD (2.55) increase 2363 19 209 1.05 (1.01–1.10) — —
Quartiles <22.8 605 4837 1.00 (ref) — —
22.8 to <24.3 513 4764 0.84 (0.75–0.95) — —
24.3 to <25.8 620 4816 1.02 (0.91–1.14) — —
‡25.8 625 4792 1.04 (0.93–1.16) — —
Ptrend
a 0.103 — —
Model 1: Adjusted for age (total number of subjects and deaths as tabulated); Model 2: Adjusted for age and BMI in 1962/66 (n = 18 995; 2337 cancer deaths);
Model 3: Adjusted for age, cigarette smoking status and physical activity at college entry and BMI in 1962/66 (n = 15 781; 1855 cancer deaths).
aP-value of test for trend.
BMI, body mass index; CI, conﬁdence intervals; HR, hazard ratio; SD, standard deviation; ref, reference.
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online). Higher middle-age BMI was inversely but
nonsigniﬁcantly associated with a decreased risk of lung cancer
mortality across quartiles (Ptrend = 0.070) (Table 4).
Results in Table 3 and supplemental Table S1 (available at
Annals of Oncology online) indicate that BMI during early
adulthood was not associated with the risk of colorectal cancer
mortality, although a 1 SD increase in middle-age BMI was
associated with a 12% increase in risk (Table 4). Results for
colon cancer mortality were similar to those found for
colorectal cancer mortality.
There were associations between higher BMI in early
adulthood and kidney cancer mortality with a 23% increased
risk for every 1 SD BMI increase (Table 3). Those in the fourth
quartile experienced more than double the risk compared with
the lowest quartile (Ptrend = 0.025). Adjusting for middle-age
BMI and early adulthood smoking and physical activity
attenuated the results. Each 1 SD increase in BMI during
middle adulthood was associated with a 46% increase in kidney
cancer mortality. Associations for all urogenital cancers were
similar to those of kidney. Oesophageal cancer mortality
exhibited an association across quartiles of BMI in early
adulthood, which remained upon adjustment for middle-age
BMI, smoking and physical activity (P = 0.030); there were no
associations of middle-age BMI with this malignancy (Table 4
and supplemental Table S2, available at Annals of Oncology
online). There was a suggestion of association of higher BMI in
early adulthood with skin cancer.
There was no apparent relation of either early- or later-life
BMI with any of the remaining malignancies: stomach,
p a n c r e a s ,l i v e r ,b r a i n ,p r o s t ate, bladder, lymphatic and
haematopoietic tissue malignancies (lymphoma, multiple
myeloma and leukaemia) (Tables 3 and 4 and supplemental
Tables S1 and S2, available at Annals of Oncology online).
When we recategorised the BMI data into standard WHO
groupings, our results were essentially unchanged. Weight gain
between early and later adulthood was associated with an
increased risk of total cancer mortality, as well as cancers of the
Table 3. HRs (95% CIs) for mortality from site-speciﬁc malignancies in relation to a 1 standard deviation (2.56 kg/m
2) increase in BMI in early adulthood
(mean age 18.4 years)
Deaths Deaths per 1000 men Model 1, HR (95% CI) Model 2, HR (95% CI) Model 3, HR (95% CI)
Lung cancer 469 23.9 1.11 (1.02–1.20) 1.18 (1.09–1.27) 1.24 (1.10–1.40)
Colorectal cancer 270 13.8 1.08 (0.96–1.21) 1.03 (0.90–1.18) 1.09 (0.93–1.27)
Colon cancer 228 11.6 1.09 (0.97–1.23) 1.05 (0.91–1.21) 1.11 (0.94–1.31)
Stomach cancer 67 3.4 0.97 (0.74–1.26) 0.93 (0.69–1.26) 0.94 (0.68–1.30)
Liver cancer 69 3.5 1.07 (0.86–1.35) 1.11 (0.87–1.41) 0.98 (0.68–1.40)
Pancreatic cancer 145 7.4 1.03 (0.87–1.22) 1.01 (0.84–1.23) 1.08 (0.87–1.34)
Prostate cancer 417 21.3 1.06 (0.97–1.17) 1.04 (0.93–1.16) 1.04 (0.91–1.19)
Kidney cancer 55 2.8 1.23 (1.07–1.41) 1.12 (0.91–1.39) 1.17 (0.84–1.62)
Bladder cancer 60 3.1 1.05 (0.81–1.36) 1.00 (0.73–1.37) 0.91 (0.63–1.60)
Urogenital cancer 535 27.3 1.09 (1.01–1.18) 1.05 (0.96–1.16) 1.05 (0.93–1.18)
Oesophageal cancer 82 4.2 1.14 (0.97–1.35) 1.17 (0.99–1.37) 1.21 (0.91–1.60)
Brain cancer 85 4.3 1.00 (0.80–1.25) 1.03 (0.80–1.33) 1.05 (0.78–1.42)
Skin cancer 66 3.4 1.19 (1.01–1.39) 1.34 (0.99–1.80) 1.29 (0.96–1.75)
Lymphoma 149 7.6 1.11 (0.96–1.28) 1.04 (0.87–1.25) 1.08 (0.87–1.34)
Multiple myeloma 58 3.0 1.19 (1.03–1.38) 1.17 (0.99–1.37) 1.23 (0.90–1.60)
Leukaemia 119 6.1 0.98 (0.80–1.19) 0.98 (0.79– 1.23) 1.12 (0.88–1.42)
Lymphatic and haematopoietic
tissue malignancies
328 16.7 1.09 (0.98–1.20) 1.06 (0.94–1.19) 1.12 (0.97–1.30)
Model 1: Adjusted for age (number and percentage of deaths as tabulated); Model 2: Adjusted for age and BMI in 1962/1966 (n = 18 995); Model 3: Adjusted
for age, cigarette smoking status and physical activity at college entry and BMI in 1962/1966 (n = 15 781).
BMI, body mass index; CI, conﬁdence intervals; HR, hazard ratio; SD, standard deviation.
Table 4. Age-adjusted HRs (95% CIs) for mortality from site-speciﬁc
malignancies in relation to a 1 standard deviation (2.55 kg/m
2) increase in




Lung cancer 459 23.9 0.93 (0.84–1.02)
Colorectal cancer 269 14.0 1.12 (1.00–1.26)
Colon cancer 227 11.8 1.14 (1.00–1.29)
Stomach cancer 67 3.5 1.10 (0.87–1.39)
Liver cancer 68 3.5 0.96 (0.75–1.23)
Pancreatic cancer 148 7.7 1.03 (0.87–1.21)
Prostate cancer 409 21.3 1.08 (0.98–1.19)
Kidney cancer 55 2.9 1.46 (1.17–1.82)
Bladder cancer 58 3.0 1.04 (0.80–1.35)
Urogenital cancer 525 27.3 1.12 (1.03–1.22)
Oesophageal cancer 81 4.2 1.05 (0.84–1.30)
Brain cancer 83 4.3 0.94 (0.75–1.18)
Skin cancer 63 3.3 1.14 (0.90–1.44)
Lymphoma 145 7.5 1.19 (1.02–1.39)
Multiple myeloma 58 3.0 1.15 (0.90–1.48)
Leukaemia 121 6.3 0.98 (0.81–1.18)
Lymphatic and haematopoietic
tissue malignancies
326 17.0 1.10 (0.99–1.18)
CI, conﬁdence intervals; HR, hazard ratio; SD, standard deviation.
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lung cancer and malignancies of the lymphatic and
haematopoietic tissue. Our results persisted in analyses
excluding deaths within 3 years of the 1962/1966 questionnaire
return and accounting for parental history of cancer. Joint
model estimation also yielded similar results. In re-analyses of
all models based on imputed data and conﬁned to the subset of
participants with completely observed data, results remained
consistent with those presented here.
discussion
The main aim of the present analyses was to examine the
relation of BMI in early adulthood with death from cancers. We
found evidence of an association between increasing early
adulthood BMI and cancer for all malignancies combined, and
those of the lung, oesophagus, skin and urogenital sites.
Conversely, BMI during middle-age BMI was inversely
associated with lung cancer death.
comparisons with other studies
The few cohorts with sufﬁcient length of follow-up (20–40
years) to investigate the role of early adulthood BMI on the
subsequent development of cancer [1, 4–6] have yielded
conﬂicting results. In one study, null ﬁndings for cancer
mortality were apparent in a small cohort of UK University
students [4]. In other cohorts, a positive association with risk of
prostate cancer (20%–22% excess risk in the overweight/obese)
was found [5], and there was a doubling of risk of colon cancer
together with null ﬁndings for larynx, lung and lymphatic
system among an adolescent population [1].
Previously, studies have examined the associations of BMI
with site-speciﬁc cancers in the Harvard Alumni Health Study
[6, 18, 22, 23], with elevated BMI associated with an increased
risk of breast cancer (in a subsample that included women) [6],
kidney and bladder cancers [6, 23], and colon cancer [18], but
null ﬁndings for other cancers including lung [6], prostate and
testis [23], and pancreatic [22] malignancies). In these studies,
follow-up extended until 1978 or 1988 with fewer cancer end
points. For this paper, an extra 10–20 years of follow-up
enabled us to re-examine these associations while accounting
for the effect of BMI during middle-age.
mechanisms
Greater caloric intake alone or in combination with reduced
physical activity has been implicated in the development of
obesity [24]. Some credible mechanisms have been proposed to
account for the relation between obesity and the increased risk
of developing cancer [24]. Endogenous hormones such as sex
steroids, insulin, and insulin-like growth factor-1 increase with
the accumulation of body fat and are involved in the control of
growth, differentiation and metabolism of cells, potentially
linking energy-dense processed carbohydrate and animal fat
consumption and cancer development. Alternative
explanations include increases in the number of adipocytes
along with associated obesity-related inﬂammatory markers
(e.g. adipokines/cytokines), the nuclear factor kappa beta
system and DNA-damaging oxidative stresses [25].
Additionally, given that birth weight is associated with weight
in adult life, links between birth weight and cancer [26] point
to the possible inﬂuence of the intrauterine environment. The
ways in which such mechanisms may act in some, but not all,
cancer subtypes are not currently clear. Alternatively, since
elevated BMI corresponds (in the same way that taller stature
does) to larger body size, there are simply more cells that may
potentially undergo malignant transformation [27].
study strengths and limitations
With the combined advantages of a large number of subjects
with measured height and weight, covariate data during early
and middle adulthood, and long-term subsequent follow-up,
this study overcomes any lack of power and unaccounted
confounding and mediation affecting previous studies.
However, our study does have some shortcomings. While we
had measured height and weight at university entry that
eliminated recall bias, the determination of BMI in middle
age relies on self-reported height and weight, whereby the
precision of self-reported values is lower than directly
measured ones. Despite this limitation, contemporary self-
reported measures are likely to be more accurate than
recalled estimates. We still cannot rule out probable residual
confounding as we lacked contemporaneous information on
diet, alcohol and other covariates. Since the cancer outcomes
were based on mortality, they reﬂect a combination of
incidence and survival rather than disease aetiology per se.
Additionally, death certiﬁcates may not accurately reﬂect the
cancer site (e.g. colon versus rectal cancer). Our results
persisted even after the exclusion of alumni dying within 3
years following the questionnaire return, indicating that this
may not be explained by reverse causality.
In conclusion, BMI during early adulthood among Harvard
undergraduates was associated with elevated rates of total
cancer plus cancer of the lung, oesophagus, skin and urogenital
sites. Unchecked, the increasing prevalence of obesity seen in
Europe, North America and emerging economic areas will be
likely to lead to an increase in the incidence of some cancers.
Effective measures to tackle the persisting obesity epidemic are
necessary to alleviate the burden of cancer and also other
chronic diseases.
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